サンプル依頼リスト カート
  • English
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1758775

フランツセルおよび水分蒸散計の世界市場

Franz Cells and Vapometers

出版日
ページ情報
英文 278 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円
フランツセルおよび水分蒸散計の世界市場
出版日: 2025年06月30日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 278 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

フランツセルおよび水分蒸散計の世界市場は2030年までに840万米ドルに達する見込み

2024年に720万米ドルと推定されるフランツセルおよび水分蒸散計の世界市場は、2024年から2030年にかけてCAGR 2.5%で成長し、2030年には840万米ドルに達すると予測されます。本レポートで分析したセグメントの1つであるフランツセルは、CAGR 3.1％を記録し、分析期間終了時には570万米ドルに達すると予測されています。水分蒸散計セグメントの成長率は、分析期間でCAGR 1.4％と推定されます。

米国市場は200万米ドルと推定、中国はCAGR 5.0％で成長予測

米国のフランツセルおよび水分蒸散計市場は、2024年に200万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに160万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは5.0%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ0.9％と1.9％と予測されています。欧州では、ドイツがCAGR 1.4%で成長すると予測されています。

世界のフランツセルおよび水分蒸散計市場- 主要動向と促進要因のまとめ

フランツセルおよび水分蒸散計が皮膚科学および医薬品検査で重要性を増している理由とは？

フランツセルおよび水分蒸散計は、皮膚研究、皮膚科学製品開発、医薬品透過性試験で幅広く使用されている特殊な機器です。フランツセルは、生体膜（最も一般的なものは皮膚）を通過する薬物や化合物の輸送速度を評価するために設計された拡散システムです。外用薬や経皮薬の製剤を試験し、その透過性、有効性、放出プロファイルを決定する上で極めて重要です。一方、水分蒸散計は経表皮水分損失（TEWL）の測定に用いられる非侵襲的なツールであり、皮膚バリア機能の評価や、外用剤が水分補給や皮膚の完全性に及ぼす影響の評価に役立っています。

これらのツールはともに、化粧品科学、経皮ドラッグデリバリー研究、規制試験において基礎となっています。高精度で再現性があり、動物を用いない試験手法に対する要求が高まるにつれ、その重要性は増しています。規制機関や工業試験所全体におけるin vitroおよびex vivo試験プロトコルへのシフトは、皮膚浸透と水分動態の倫理的、効率的、定量可能な評価を可能にするFranz拡散セルと水分蒸散計の重要性をさらに強めています。

技術的進歩は分析精度と試験スループットをどのように向上させているか？

最新のフランツセルシステムは、自動化、温度制御精度、ドナーとレセプターの界面材料の強化などの恩恵を受けています。改良されたガラス器具構成、モジュラーシステム、マルチセル拡散セットアップにより、製薬会社や化粧品メーカーが大規模な比較試験を実施する際に不可欠な、よりスループットの高い製剤のスクリーニングが可能になっています。合成膜やヒトまたは動物の皮膚サンプルとの互換性により柔軟性が増し、リアルタイムサンプリングポートの統合により、薬物透過の経時的動態解析が容易になりました。

水分蒸散計も同様に、デジタル表示、自動キャリブレーション、皮膚表面との一貫した接触を保証する人間工学的デザインで進化しています。ワイヤレスのハンドヘルドTEWLメーターとマルチセンサーアレイの導入により、臨床試験や消費者製品試験において、迅速で再現性のある水分バリア評価が可能になりました。これらの機器は現在、デジタル・データ・ロギング・システムと統合されつつあり、研究者が異なる皮膚ゾーン、製品タイプ、患者の状態にわたって包括的な水分プロファイルを作成することを可能にしています。このような機能強化により、フランツセルおよび水分蒸散計は皮膚薬理学および製品安全性検証における標準的な分析ツールとして、その有用性が強化されつつあります。

市場需要を牽引する業界と使用事例は？

フランツセルおよび水分蒸散計の主な需要は、製薬会社、化粧品・パーソナルケアメーカー、研究所、臨床皮膚科学センターから生じています。製薬会社では、フランツ細胞はジェネリック経皮製剤の生物学的同等性の検証、新規皮膚パッチの評価、経皮薬剤候補の浸透試験の実施など、薬剤開発パイプラインで使用されています。また、規制当局への申請においても中心的な役割を担っており、外用薬の承認にはin vitro透過性データがますます求められるようになっています。

化粧品メーカーは、肌の保湿、アンチエイジング、有効成分の経皮吸収に関する主張を裏付けるために、この2つのツールを使用しています。蒸気圧計は、保湿剤、日焼け止め、バリア修復製剤の製品ポジショニングにおいて重要な役割を果たし、皮膚バリア改善に関する客観的データを提供しています。学術機関や受託研究機関（CRO）も、特に皮膚毒性スクリーニング、製剤最適化、材料研究のための重要なユーザーです。さらに、スキンケア診断や臨床試験は、一般用医薬品（OTC）や皮膚化粧品の定量的な有効性試験のためにこれらのツールを採用しています。

フランツセルおよび水分蒸散計市場の主な成長促進要因は？

フランツセルおよび水分蒸散計市場の成長は、最終用途の革新、規制のシフト、試験の標準化に関するいくつかの要因によってもたらされます。主な促進要因は、特に化粧品や医薬品の開発において、動物実験に代わるin vitroや非侵襲的な試験に対する需要が高まっていることです。欧州、北米、アジアの規制当局は、Franz拡散システムのような有効で再現性の高いモデルを用いた透過性試験や皮膚刺激性試験を奨励するようになっており、市場拡大を後押ししています。

また、経皮吸収・放出動態の正確なプロファイリングを必要とする経皮ドラッグデリバリー研究が急増していることも追い風となっています。同様に、高機能スキンケアや化粧品の普及により、各ブランドはベーパーメーターのような先進的なTEWL測定ツールを使って宣伝文句を検証するようになっています。また、臨床および消費者環境における皮膚健康モニタリングツールの広範な採用により、携帯可能でユーザーフレンドリーな機器への関心が高まっていることも成長を後押ししています。ラボの自動化、リアルタイム分析、合成皮膚代替物への投資は、これらのシステムの商業的実行可能性をさらに高め、フランツセルおよび水分蒸散計を現代の皮膚科学と製剤試験における不可欠なツールとして位置づけています。

セグメント

製品（フランツセル、水分蒸散計）;エンドユーザー（製薬会社、学術・研究機関、CRO/CDMO）

調査対象企業の例（注目の44社）

  • ABL&E-JASCO
  • Bionanoplus
  • Delfin Technologies Ltd.
  • Dissolution Accessories
  • IDM Instruments Pty Ltd.
  • JN Sciencetech
  • Orchid Scientific
  • PermeGear, Inc.
  • SES Analysesysteme GmbH
  • Teledyne Hanson Research
  • Thwing-Albert Instrument Company
  • Xenometrix AG
  • Biox Systems Ltd.
  • EnvisBE Solutions
  • Delfin USA
  • IndustryStock.com
  • HGR Industrial Surplus
  • Delfin Technologies-Teledyne Labs
  • Skinobs
  • Rycobel NV

AIインテグレーション

私たちは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、膨大な量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP36937

Global Franz Cells and Vapometers Market to Reach US$8.4 Million by 2030

The global market for Franz Cells and Vapometers estimated at US$7.2 Million in the year 2024, is expected to reach US$8.4 Million by 2030, growing at a CAGR of 2.5% over the analysis period 2024-2030. Franz Cells, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$5.7 Million by the end of the analysis period. Growth in the Vapometers segment is estimated at 1.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.0 Million While China is Forecast to Grow at 5.0% CAGR

The Franz Cells and Vapometers market in the U.S. is estimated at US$2.0 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Million by the year 2030 trailing a CAGR of 5.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.4% CAGR.

Global Franz Cells and Vapometers Market - Key Trends & Drivers Summarized

Why Are Franz Cells and Vapometers Gaining Significance in Dermatological and Pharmaceutical Testing?

Franz cells and vapometers are specialized instruments used extensively in skin research, dermatological product development, and pharmaceutical permeability testing. Franz cells are diffusion systems designed to evaluate the rate of drug or compound transport across biological membranes-most commonly, skin. They are crucial in testing topical and transdermal drug formulations to determine their permeability, efficacy, and release profiles. Vapometers, on the other hand, are non-invasive tools used to measure transepidermal water loss (TEWL), helping assess skin barrier function and the impact of topical products on hydration and skin integrity.

Together, these tools have become foundational in cosmetic science, transdermal drug delivery research, and regulatory testing. Their relevance is increasing as the demand grows for high-precision, reproducible, and non-animal testing methodologies. The shift toward in vitro and ex vivo testing protocols across regulatory and industrial laboratories further reinforces the importance of Franz diffusion cells and vapometers in enabling ethical, efficient, and quantifiable assessments of skin penetration and moisture dynamics.

How Are Technological Advancements Enhancing Analytical Accuracy and Testing Throughput?

Modern Franz cell systems are benefiting from automation, temperature control precision, and enhanced donor-receptor interface materials. Improved glassware configurations, modular systems, and multi-cell diffusion setups are enabling higher-throughput screening of formulations, essential for pharmaceutical companies and cosmetic manufacturers running large-scale comparative tests. Compatibility with synthetic membranes and human or animal skin samples allows flexibility, while the integration of real-time sampling ports facilitates kinetic analysis of drug permeation over time.

Vapometers are similarly evolving with digital displays, automated calibration, and ergonomic designs that ensure consistent contact with the skin surface. The introduction of wireless, handheld TEWL meters and multi-sensor arrays allows fast, reproducible moisture barrier assessments in clinical and consumer product trials. These instruments are now being integrated with digital data logging systems, enabling researchers to generate comprehensive moisture profiles across different skin zones, product types, and patient conditions. These enhancements are strengthening the utility of both Franz cells and vapometers as standard analytical tools in dermatopharmacology and product safety validation.

Which Industries and Use Cases Are Driving Market Demand?

The primary demand for Franz cells and vapometers arises from pharmaceutical companies, cosmetic and personal care manufacturers, research laboratories, and clinical dermatology centers. In pharma, Franz cells are used in drug development pipelines to validate bioequivalence of generic transdermal formulations, evaluate novel skin patches, and conduct permeation studies on dermal drug candidates. They are also central to regulatory submissions, where in vitro permeability data is increasingly required for topical drug approvals.

Cosmetic manufacturers use both tools to support claims around skin hydration, anti-aging performance, and dermal absorption of active ingredients. Vapometers play a key role in product positioning for moisturizers, sunscreens, and barrier-repair formulations, providing objective data on skin barrier improvement. Academic institutions and contract research organizations (CROs) are also important users, especially for dermatotoxicity screening, formulation optimization, and materials research. Additionally, skin care diagnostics and clinical trials are adopting these tools for quantitative efficacy testing of over-the-counter (OTC) and dermocosmetic products.

What Are the Key Growth Drivers in the Franz Cells and Vapometers Market?

The growth in the Franz cells and vapometers market is driven by several factors related to end-use innovation, regulatory shifts, and testing standardization. A key driver is the rising demand for in vitro and non-invasive alternatives to animal testing, especially in cosmetic and pharmaceutical development. Regulatory authorities across Europe, North America, and Asia are increasingly encouraging permeability and skin irritation studies using validated, reproducible models like Franz diffusion systems, supporting market expansion.

Another driver is the surge in transdermal drug delivery research, which requires precise dermal absorption and release kinetics profiling. Similarly, the proliferation of high-performance skincare and cosmetic products is prompting brands to validate claims using advanced TEWL measurement tools like vapometers. Growth is also bolstered by the broader adoption of skin health monitoring tools in clinical and consumer environments, driving interest in portable, user-friendly instruments. Investments in lab automation, real-time analytics, and synthetic skin substitutes are further enhancing the commercial viability of these systems, positioning Franz cells and vapometers as essential tools in modern dermatological science and formulation testing.

SCOPE OF STUDY:

The report analyzes the Franz Cells and Vapometers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Franz Cells, Vapometers); End-Use (Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use, CROs / CDMOs End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • ABL&E-JASCO
  • Bionanoplus
  • Delfin Technologies Ltd.
  • Dissolution Accessories
  • IDM Instruments Pty Ltd.
  • JN Sciencetech
  • Orchid Scientific
  • PermeGear, Inc.
  • SES Analysesysteme GmbH
  • Teledyne Hanson Research
  • Thwing-Albert Instrument Company
  • Xenometrix AG
  • Biox Systems Ltd.
  • EnvisBE Solutions
  • Delfin USA
  • IndustryStock.com
  • HGR Industrial Surplus
  • Delfin Technologies - Teledyne Labs
  • Skinobs
  • Rycobel NV

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Franz Cells and Vapometers - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Emphasis on Transdermal Drug Delivery Research Fuels Demand for Franz Diffusion Cells
    • Growth in Cosmetic and Dermatological Formulation Testing Expands Use of Vapometers
    • Expansion of Generic Drug Development Drives Demand for Bioequivalence Testing Platforms
    • Increasing Adoption of Skin Permeation Studies Across Pharmaceutical R&D Boosts Cell Usage
    • Technological Advancements in Flow-Through and Static Franz Cells Enhance Application Versatility
    • Surge in Demand for Non-Animal Testing Methods Strengthens Business Case for Diffusion Cells
    • Rising Investment in Controlled Release and Nano-Emulsion Technologies Fuels Market Penetration
    • Global Expansion of Contract Research Organizations (CROs) Supports Equipment Utilization
    • Development of Skin-Mimetic Membranes Enhances Realism and Reproducibility in Testing
    • Customization of Franz Cells for Ocular and Buccal Membrane Studies Broadens Market Applications
    • Automation and Digitization of Analytical Instruments Improve Accuracy and Throughput
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Franz Cells and Vapometers Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Franz Cells and Vapometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Franz Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Franz Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Franz Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Vapometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Vapometers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Vapometers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Pharmaceuticals Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Pharmaceuticals Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Pharmaceuticals Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for CROs / CDMOs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for CROs / CDMOs End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for CROs / CDMOs End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 22: USA 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 28: Canada 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • JAPAN
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 34: Japan 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • CHINA
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 40: China 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 43: China 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • EUROPE
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Franz Cells and Vapometers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 46: Europe 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • FRANCE
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 55: France 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 58: France 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • GERMANY
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 61: Germany 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 67: Italy 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 73: UK 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 79: Spain 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 85: Russia 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Franz Cells and Vapometers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 106: Australia 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • INDIA
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 112: India 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 115: India 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 118: South Korea 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Franz Cells and Vapometers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 130: Latin America 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 139: Argentina 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 145: Brazil 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 151: Mexico 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Franz Cells and Vapometers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 163: Middle East 16-Year Perspective for Franz Cells and Vapometers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 172: Iran 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 178: Israel 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 190: UAE 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030
  • AFRICA
    • Franz Cells and Vapometers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Franz Cells and Vapometers by Product - Franz Cells and Vapometers - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Franz Cells and Vapometers by Product - Franz Cells and Vapometers Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 202: Africa 16-Year Perspective for Franz Cells and Vapometers by Product - Percentage Breakdown of Value Sales for Franz Cells and Vapometers for the Years 2014, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Franz Cells and Vapometers by End-Use - Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2023 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Franz Cells and Vapometers by End-Use - Percentage Breakdown of Value Sales for Pharmaceuticals Companies End-Use, Academic & Research Institutes End-Use and CROs / CDMOs End-Use for the Years 2014, 2025 & 2030

IV. COMPETITION